Get started
Author

Fadel S. Alyaqoub

Observed names: F. Alyaqoub, F. S. Alyaqoub, Fadel Alyaqoub, Fadel S Alyaqoub
OpenAlex ID: A5015748359
ERAP1 deficient mice have reduced Type 1 regulatory T cells and develop skeletal and intestinal features of Ankylosing Spondylitis
2018 · Yuliya Pepelyayeva, David P. W. Rastall, et al. · Scientific Reports · 44
PDF
Prevention of mouse lung tumors by targretin
2005 · Michael A. Pereira, Paula M. Kramer, et al. · International Journal of Cancer · 27
PDF
Modulation by bexarotene of mRNA expression of genes in mouse lung tumors
2007 · Fadel S. Alyaqoub, Yue Liu, et al. · Molecular Carcinogenesis · 15
In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens
2016 · Fadel S Alyaqoub, Yasser A Aldhamen, et al. · The Journal of Immunology · 14
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT)
2006 · F. S. Alyaqoub, L. Tao, et al. · Carcinogenesis · 14
Apoptotic proteins and cancer: many faces.
2012 · Faris Q Alenzi, Mohamed L Salem, et al. · PubMed · 4
CGE23-072: The Frequency of Androgen Receptor Splice Variant 7 (AR-V7) in Solid Tumors
2023 · Zoran Gatalica, Jess Hoag, et al. · Journal of the National Comprehensive Cancer Network · 1
Genomic profiling of gastrointestinal cancers by comprehensive tumor-normal sequencing.
2021 · Fadel S. Alyaqoub, Pawan Noel, et al. · Journal of Clinical Oncology · 1
Abstract 2994: Engineered STING-targeting immunotherapy delays B16 melanoma tumor growth and significantly improves animal survival as compared to an immune-checkpoint inhibitor
2017 · Andrea Amalfitano, Fadel S. Alyaqoub, et al. · Cancer Research · 1
Abstract P3-03-30: Molecular landscape of breast cancer in pre- and postmenopausal women
2025 · Sameer Udhane, Pawan Noel, et al. · Clinical Cancer Research
Landscape of novel gene fusions in gastrointestinal tumors.
2025 · Aysegul Balyimez, Karen L White, et al. · Journal of Clinical Oncology
Abstract A022: Assessment of clonal and subclonal PIK3CA mutations in patients with breast cancer
2024 · Sameer S Udhane, Fadel Alyaqoub, et al. · Cancer Research
Abstract P5-14-12: ESR1-alterations in HR+HER2- breast cancer patients
2023 · Gargi Basu, Sameer S. Udhane, et al. · Cancer Research
Erythroblast transformation-specific transcription factor fusions in prostate cancer.
2023 · Michelle Barbi de Moura, Fadel S. Alyaqoub, et al. · Journal of Clinical Oncology
Prevalence and genomic landscape of BRAF alterations across gastrointestinal cancers.
2023 · David Driscoll, Min Wang, et al. · Journal of Clinical Oncology
351P Prevalence of ERBB alterations in colorectal cancer patients using genomic profiling
2022 · M.N. Kundranda, M. Wang, et al. · Annals of Oncology
Abstract 1263: Comprehensive genomic profiling to identify biomarkers predictive of response to immunotherapy
2022 · Pawan Noel, David W. Hall, et al. · Cancer Research
Comprehensive genomic profiling to identify gene alterations in DNA repair pathway across solid tumors.
2022 · Kevin McDonnell, Gargi D. Basu, et al. · Journal of Clinical Oncology
Comprehensive whole-exome and transcriptome profiling to identify actionable alterations associated with response to PARP inhibitors in breast cancer.
2022 · Susan M. Dombrowski, Sameer S. Udhane, et al. · Journal of Clinical Oncology
Endoplasmic Reticulum Aminopeptidase I-driven Production of IL-18 and IL-1β Protects from Severe Intestinal Inflammation and Mortality during Experimental Colitis
2016 · Yasser Ali Aldhamen, Fadel S Alyaqoub, et al. · The Journal of Immunology
Chemoprevention and modulation of molecular biomarkers in mouse lung tumors.
2005 · Fadel S. Alyaqoub · OhioLink ETD Center (Ohio Library and Information Network)
PDF
Works count: 21
Citation count: 121
H-index: 5
I10-index: 5
Year
Topic
Type